ᱵᱮᱱᱡᱳᱠᱟᱭᱤᱱ

ᱵᱮᱱᱡᱳᱠᱟᱭᱤᱱ
ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ
ᱵᱮᱯᱟᱨ ᱧᱩᱛᱩᱢᱠᱚ	Anbesol, Lanacane, Orajel, others
ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ	Benzocaine (Topical) Monograph; Benzocaine (EENT) Monograph;
ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ; ᱴᱷᱟᱶ	Topical, Oral
ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ	C05AD03 (WHO) ᱪᱷᱟᱸᱪ:ATC, ᱪᱷᱟᱸᱪ:ATCvet, ᱪᱷᱟᱸᱪ:ATC, ᱪᱷᱟᱸᱪ:ATC;
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ	AU: S4 (Prescription only) / Schedule 2; UK: GSL, P ; US: OTC ;
ᱩᱯᱨᱩᱢᱤᱭᱟᱹ
	ᱟᱭ.ᱭᱩ.ᱯᱤ.ᱮ.ᱥᱤ ᱧᱩᱛᱩᱢ Ethyl 4-aminobenzoate;
ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ	94-09-7;
ᱯᱟᱵᱽᱠᱮᱢ ᱥᱤ.ᱟᱭ.ᱰᱤ	2337;
ᱰᱨᱟᱜᱵᱮᱸᱠ	DB01086;
ᱠᱮᱢᱥᱯᱟᱭᱰᱟᱨ	13854242;
ᱭᱩ.ᱮᱱ.ᱟᱭ.ᱟᱭ	U3RSY48JW5;
ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ	D00552;
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱵᱤ.ᱟᱭ	CHEBI:116735;
ᱥᱤ.ᱮᱭᱤᱪ.ᱤ.ᱮᱢ.ᱵᱤ.ᱮᱞ	ChEMBL278172;
ECHA InfoCard	100.002.094
Chemical and physical data
ᱯᱷᱚᱨᱢᱩᱞᱟ	C9H11NO2
ᱢᱤᱞᱟᱨ ᱢᱟᱥ	Error in {{val}}: parameter 1 is not a valid number. g·mol−1
ᱛᱷᱨᱤᱰᱤ ᱢᱚᱰᱮᱞ (ᱡᱮ.ᱮᱥ.ᱢᱳᱞ)	Interactive image;
	ᱮᱥ.ᱮᱢ.ᱟᱭ.ᱮᱞ.ᱤ.ᱮᱥ O=C(OCC)c1ccc(N)cc1;
	ᱟᱭ.ᱮᱱ.ᱥᱤ.ᱮᱭᱤᱪ.ᱮᱞ InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3; Key:BLFLLBZGZJTVJG-UHFFFAOYSA-N;

ᱢᱮᱰᱤᱠᱟᱞ ᱵᱮᱣᱦᱟᱨ

↑ "Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025" (pdf). Therapeutic Goods Administration (TGA). May 2025. Retrieved August 31, 2025.